This inventor holds 1 USPTO granted patent. Top assignee: Gpc Biotech Ag. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Sabine Obert: Innovator in Hepatitis C Virus Treatment
Introduction
Sabine Obert is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of medical research, particularly in the treatment of Hepatitis C virus (HCV) infections. Her innovative work has led to the development of therapeutic targets that hold promise for improving patient outcomes.
Latest Patents
Sabine Obert holds a patent titled "Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor." This invention focuses on the human cellular protein glutathione peroxidase-gastrointestinal as a target for medical intervention against HCV infections. The patent also outlines methods for detecting compounds that can be used for the prophylaxis and treatment of HCV infections, as well as methods for identifying HCV infections in individuals or cells. Additionally, it discloses various compositions, compounds, nucleic acid molecules, and antibodies that are effective in treating HCV infections.
Career Highlights
Throughout her career, Sabine Obert has been associated with GPC Biotech AG, where she has played a crucial role in advancing research related to HCV. Her dedication to innovation in the medical field has positioned her as a key figure in the fight against viral infections.
Collaborations
Sabine has collaborated with notable colleagues, including Thomas Herget and Matthew Cotten. These partnerships have further enhanced her research efforts and contributed to the development of effective treatments for HCV.
Conclusion
Sabine Obert's work in the field of Hepatitis C virus treatment exemplifies the impact of innovative research on public health. Her contributions continue to pave the way for new therapeutic approaches and improved patient care.